SCHEMBL20845319

SCHEMBL20845319

C1=C\c2ccc(-c3nc(-c4cccc(-c5ccccc5)c4)nc(-c4cccc(-c5ccccc5)c4)n3)cc2-c2ccccc2Sc2ccccc2-c2ccccc2/1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GP6 Q9HCN6 1/20 0.33
▸ MEN1 O00255 5/20 0.33
▸ KMT2A Q03164 5/20 0.33
▸ MAPT P10636 4/20 0.33
▸ LMNA P02545 3/20 0.33
▸ APAF1 O14727 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ XBP1 P17861 1/20 0.33
▸ PTBP1 P26599 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ GALK1 P51570 1/20 0.33
▸ BLM P54132 1/20 0.33
▸ SMAD3 P84022 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ ALDH1A1 P00352 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20845323 0.99 MEN1 (0.34) GP6MEN1KMT2AMAPTLMNA
SCHEMBL20845325 0.95 MEN1 (0.36) MEN1KMT2AMAPTLMNAAPAF1
SCHEMBL20845322 0.94 MEN1 (0.34) MEN1KMT2AMAPTLMNAHTT
SCHEMBL20845141 0.93 MEN1 (0.37) MEN1KMT2AMAPTLMNANPC1
SCHEMBL20845318 0.93 NPC1 (0.34) NPC1RAB9ASMN1; SMN2
SCHEMBL20845314 0.88 CYP11B1 (0.41) MEN1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL20845239 0.88 MEN1 (0.42) MEN1KMT2AMAPTLMNASMN1; SMN2
SCHEMBL20845333 0.87 KDM4E (0.33) MAPTATMSMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL20845137 0.85 MEN1 (0.37) MEN1KMT2AMAPTLMNAATM
SCHEMBL20222671 0.85 MEN1 (0.47) GP6MEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190092745-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2019-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190092745-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME SCO2, AOX1, ORC3 GP6 4338/4885MEN1 3151/4885KMT2A 880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback